We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

121 hedge funds and large institutions have $248M invested in Rigel Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $115K | Put options by funds: $35K

58% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 31

26% more capital invested

Capital invested by funds: $197M → $248M (+$50.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 122 → 121 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
121
Holders Change
-1
Holders Change %
-0.82%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
49
Reduced
31
Closed
10
Calls
$115K
Puts
$35K
Net Calls
+$80K
Net Calls Change
+$61K

Top Buyers

1
RSCM
Rock Springs Capital Management
Maryland
+$3.34M
2
BFA
BlackRock Fund Advisors
California
+$3.33M
3
PC
Paulson & Co
New York
+$1.6M
4
Millennium Management
Millennium Management
New York
+$1.12M
5
ACP
Acuta Capital Partners
California
+$776K

Top Sellers

1
BC
Broadfin Capital
New York
-$6.06M
2
TC
TFS Capital
Pennsylvania
-$843K
3
UBS AM
UBS AM
Illinois
-$634K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$619K
5
MOACM
Mutual of America Capital Management
New York
-$422K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
76
Algert Global
California
$167K – – –
AIG
77
American International Group
New York
$156K -$273 -9 -0.2%
Nomura Holdings
78
Nomura Holdings
Japan
$147K -$78.1K -2,577 -35%
JMPWA
79
JP Morgan Private Wealth Advisors
California
$143K – – –
SKK
80
Shepherd Kaplan Krochuk
Massachusetts
$139K -$215K -7,096 -61%
SGAM
81
Smith Group Asset Management
Texas
$133K +$25.4K +839 +24%
VKH
82
Virtu KCG Holdings
New York
$127K -$104K -3,428 -45%
VOYA Investment Management
83
VOYA Investment Management
Georgia
$125K – – –
RCM
84
Rotella Capital Management
Washington
$120K -$69.9K -2,306 -37%
Citigroup
85
Citigroup
New York
$117K +$117K +3,854 +32,117%
Public Employees Retirement Association of Colorado
86
Public Employees Retirement Association of Colorado
Colorado
$115K – – –
CCMH
87
Cornerstone Capital Management Holdings
New York
$86K +$23K +760 +37%
Bank of America
88
Bank of America
North Carolina
$85K +$75K +2,475 +764%
BIP
89
Brandes Investment Partners
California
$76K – – –
Susquehanna International Group
90
Susquehanna International Group
Pennsylvania
$76K +$24.4K +804 +47%
Wells Fargo
91
Wells Fargo
California
$75K -$17.7K -585 -19%
BFM
92
Boothbay Fund Management
New York
$74K +$22.7K +750 +44%
SG Americas Securities
93
SG Americas Securities
New York
$66K +$65.6K +2,164 New
Tudor Investment Corp
94
Tudor Investment Corp
Connecticut
$64K +$6.67K +220 +12%
PCM
95
Prelude Capital Management
New York
$63K -$28.3K -935 -31%
DLHL
96
Donald L. Hagan LLC
Florida
$61K – – –
FSA
97
Franklin Street Advisors
North Carolina
$61K – – –
EGA
98
Eagle Global Advisors
Texas
$60K +$60.1K +1,982 New
Acadian Asset Management
99
Acadian Asset Management
Massachusetts
$59K +$57.8K +1,907 +4,651%
Legal & General Group
100
Legal & General Group
United Kingdom
$53K – – –
2 3
4
5 6

RIGL Hedge Fund Activity: Q4 2015 in Review

121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2015, worth a combined $248M — up 26% from $197M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RIGL and 9 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 49 added.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $3.34M. The largest seller was Broadfin Capital, cutting an estimated $6.06M.

  • 121 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2015, down from 122 in Q3 2015.
  • Funds reported $248M of Rigel Pharmaceuticals stock for Q4 2015, up 26% quarter-over-quarter.
  • 9 funds opened new Rigel Pharmaceuticals positions in Q4 2015 and 10 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q4 2015 was Rock Springs Capital Management, an estimated $3.34M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2015 was Broadfin Capital, an estimated $6.06M sold.

Based on aggregated 13F filings for Q4 2015.